Literature DB >> 8970995

Mutations within DR2 independently reduce the amount of both minus- and plus-strand DNA synthesized during duck hepatitis B virus replication.

D D Loeb1, R Tian, K J Gulya.   

Abstract

The initial aim of this study was to examine the role of complementarity between the plus-strand primer and the minus-strand DNA template for translocation of the plus-strand primer in hepadnaviral replication. We show that when a 5-nucleotide substitution was placed in either DR1 or DR2, translocation of the primer at a detectable level did not occur. Placing the mutation in both DR1 and DR2 did not restore primer translocation, which indicates that complementarity is not the sole determinant for primer translocation. These mutants, in which primer translocation has been inhibited, have been additionally informative. The mutation in DR1 led to efficient synthesis of plus-strand DNA, albeit primed in situ. In contrast, the mutation in DR2 resulted in a reduction in the amount of plus-strand DNA synthesized per unit of minus-strand DNA. These findings were interpreted as indicating that a mutation at DR2, the primer acceptor site, can inhibit both primer translocation and in situ priming. Lastly, we show that mutations within DR2 can result in a reduction in the synthesis of minus-strand DNA and that this reduction is occurring at an early phase of the process. We speculate that this reduction in the amount of minus-strand DNA synthesized could be due to an inhibition of the template switch during minus-strand DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8970995      PMCID: PMC190963     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Evidence that a capped oligoribonucleotide is the primer for duck hepatitis B virus plus-strand DNA synthesis.

Authors:  J M Lien; C E Aldrich; W S Mason
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

2.  Initiation and termination of duck hepatitis B virus DNA synthesis during virus maturation.

Authors:  J M Lien; D J Petcu; C E Aldrich; W S Mason
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

3.  DNA of a human hepatitis B virus candidate.

Authors:  W S Robinson; D A Clayton; R L Greenman
Journal:  J Virol       Date:  1974-08       Impact factor: 5.103

4.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel; J D Roberts; R A Zakour
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

5.  Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus.

Authors:  W S Mason; G Seal; J Summers
Journal:  J Virol       Date:  1980-12       Impact factor: 5.103

6.  Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate.

Authors:  J Summers; W S Mason
Journal:  Cell       Date:  1982-06       Impact factor: 41.582

7.  Genomic sequencing.

Authors:  G M Church; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

8.  Isolation and characterization of a hepatitis B virus endemic in herons.

Authors:  R Sprengel; E F Kaleta; H Will
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

9.  Comparative sequence analysis of duck and human hepatitis B virus genomes.

Authors:  R Sprengel; C Kuhn; H Will; H Schaller
Journal:  J Med Virol       Date:  1985-04       Impact factor: 2.327

10.  A virus in Beechey ground squirrels that is related to hepatitis B virus of humans.

Authors:  P L Marion; L S Oshiro; D C Regnery; G H Scullard; W S Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

View more
  10 in total

1.  Small DNA hairpin negatively regulates in situ priming during duck hepatitis B virus reverse transcription.

Authors:  Jeffrey W Habig; Daniel D Loeb
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Mutations that increase in situ priming also decrease circularization for duck hepatitis B virus.

Authors:  D D Loeb; R Tian
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  cis-Acting sequences that contribute to synthesis of minus-strand DNA are not conserved between hepadnaviruses.

Authors:  Megan L Maguire; Daniel D Loeb
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

4.  cis-Acting sequences that contribute to the synthesis of relaxed-circular DNA of human hepatitis B virus.

Authors:  Ning Liu; Lin Ji; Megan L Maguire; Daniel D Loeb
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

5.  Sequence identity of the direct repeats, DR1 and DR2, contributes to the discrimination between primer translocation and in situ priming during replication of the duck hepatitis B virus.

Authors:  Jeffrey W Habig; Daniel D Loeb
Journal:  J Mol Biol       Date:  2006-09-07       Impact factor: 5.469

6.  cis-Acting sequences in addition to donor and acceptor sites are required for template switching during synthesis of plus-strand DNA for duck hepatitis B virus.

Authors:  M B Havert; D D Loeb
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

7.  Complementarity between epsilon and phi sequences in pregenomic RNA influences hepatitis B virus replication efficiency.

Authors:  Claudia E Oropeza; Alan McLachlan
Journal:  Virology       Date:  2006-10-23       Impact factor: 3.616

8.  Comparison of hepatitis B X gene mutation between patients with hepatocellular carcinoma and patients with chronic hepatitis B.

Authors:  Wenmei Fan; Bingyi Shi; Hongshan Wei; Guosheng Du; Shujing Song
Journal:  Virus Genes       Date:  2010-12-16       Impact factor: 2.332

9.  Analysis of duck hepatitis B virus reverse transcription indicates a common mechanism for the two template switches during plus-strand DNA synthesis.

Authors:  Michael B Havert; Lin Ji; Daniel D Loeb
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

10.  Changing the site of initiation of plus-strand DNA synthesis inhibits the subsequent template switch during replication of a hepadnavirus.

Authors:  D D Loeb; R Tian; K J Gulya; A E Qualey
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.